Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Translating stem cell therapy to the clinic: déjà vu all over again.

Literature DB >> 19789557

Translating stem cell therapy to the clinic: déjà vu all over again.

Ronald G Crystal.

Abstract

Mesh：

Year: 2009 PMID： 19789557 PMCID： PMC2835001 DOI： 10.1038/mt.2009.215

Source DB: PubMed Journal: Mol Ther ISSN： 1525-0016 Impact factor: 11.454

× No keyword cloud information.

5 in total

1. Medicine. A history lesson for stem cells.

Authors: James M Wilson
Journal: Science Date: 2009-05-08 Impact factor: 47.728

2. Mice made from induced stem cells.

Authors: David Cyranoski
Journal: Nature Date: 2009-07-30 Impact factor: 49.962

3. Variation in the safety of induced pluripotent stem cell lines.

Authors: Kyoko Miura; Yohei Okada; Takashi Aoi; Aki Okada; Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Mari Ohnuki; Daisuke Ogawa; Eiji Ikeda; Hideyuki Okano; Shinya Yamanaka
Journal: Nat Biotechnol Date: 2009-07-09 Impact factor: 54.908

4. Genetic control of wayward pluripotent stem cells and their progeny after transplantation.

Authors: Maija Kiuru; Julie L Boyer; Timothy P O'Connor; Ronald G Crystal
Journal: Cell Stem Cell Date: 2009-04-03 Impact factor: 24.633

5. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.

Authors: Ninette Amariglio; Abraham Hirshberg; Bernd W Scheithauer; Yoram Cohen; Ron Loewenthal; Luba Trakhtenbrot; Nurit Paz; Maya Koren-Michowitz; Dalia Waldman; Leonor Leider-Trejo; Amos Toren; Shlomi Constantini; Gideon Rechavi
Journal: PLoS Med Date: 2009-02-17 Impact factor: 11.069

5 in total

3 in total

Translating stem cell therapy to the clinic: déjà vu all over again.

1. Medicine. A history lesson for stem cells.

2. Mice made from induced stem cells.

3. Variation in the safety of induced pluripotent stem cell lines.

4. Genetic control of wayward pluripotent stem cells and their progeny after transplantation.

5. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.

Review 1. Technology advancement for integrative stem cell analyses.

2. Strategy escalation: an emerging paradigm for safe clinical development of T cell gene therapies.

3. Characteristics of Human Endometrial Stem Cells in Tissue and Isolated Cultured Cells: An Immunohistochemical Aspect.